{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:50:58Z","timestamp":1792165858500,"version":"4.4.0"},"reference-count":203,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Manipal University Jaipur"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Neurobiol"],"DOI":"10.1007\/s10571-026-01702-0","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T03:45:08Z","timestamp":1775187908000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Narrative Review \u201cDual Frontiers in Neurodegeneration: Pharmacological Synergies and Divergences in Parkinson\u2019s Disease and Type 2 Diabetes Mellitus\u201d"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7046-6680","authenticated-orcid":false,"given":"Omnya A.","family":"Sharallah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2772-364X","authenticated-orcid":false,"given":"Vishnu","family":"Malakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9503-2149","authenticated-orcid":false,"given":"Ahmed E.","family":"Salama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1081-6126","authenticated-orcid":false,"given":"Salma M.","family":"Elmaaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5031-8414","authenticated-orcid":false,"given":"Salma A.","family":"Daba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2162-9110","authenticated-orcid":false,"given":"Nitesh Kumar","family":"Poddar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,3]]},"reference":[{"key":"1702_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.prdoa.2024.100265","volume":"11","author":"Y Aguirre-Vidal","year":"2024","unstructured":"Aguirre-Vidal Y, Montes S, Mota-L\u00f3pez AC, Navarrete-V\u00e1zquez G (2024) Antidiabetic drugs in Parkinson\u2019s disease. Clinical Parkinsonism & Related Disorders 11:100265. https:\/\/doi.org\/10.1016\/j.prdoa.2024.100265","journal-title":"Clinical Parkinsonism & Related Disorders"},{"key":"1702_CR3","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nrneurol.2017.185","volume":"14","author":"SE Arnold","year":"2018","unstructured":"Arnold SE, Arvanitakis Z, Macauley-Rambach SL et al (2018) Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums. Nat Rev Neurol 14:168\u2013181. https:\/\/doi.org\/10.1038\/nrneurol.2017.185","journal-title":"Nat Rev Neurol"},{"key":"1702_CR2","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.nbd.2014.03.011","volume":"67","author":"SE Arnold","year":"2014","unstructured":"Arnold SE, Lucki I, Brookshire BR et al (2014) High fat diet produces brain insulin resistance, synaptodendritic abnormalities and altered behavior in mice. Neurobiol Dis 67:79\u201387. https:\/\/doi.org\/10.1016\/j.nbd.2014.03.011","journal-title":"Neurobiol Dis"},{"key":"1702_CR4","doi-asserted-by":"publisher","first-page":"8163","DOI":"10.1021\/acs.nanolett.0c03260","volume":"20","author":"WE Arter","year":"2020","unstructured":"Arter WE, Xu CK, Castellana-Cruz M et al (2020) Rapid structural, kinetic, and immunochemical analysis of Alpha-Synuclein oligomers in solution. Nano Lett 20:8163\u20138169. https:\/\/doi.org\/10.1021\/acs.nanolett.0c03260","journal-title":"Nano Lett"},{"key":"1702_CR5","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.exger.2014.10.002","volume":"68","author":"NM Ashpole","year":"2015","unstructured":"Ashpole NM, Sanders JE, Hodges EL et al (2015) Growth hormone, insulin-like growth factor-1 and the aging brain. Exp Gerontol 68:76\u201381. https:\/\/doi.org\/10.1016\/j.exger.2014.10.002","journal-title":"Exp Gerontol"},{"key":"1702_CR6","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.pneurobio.2016a.10.001","volume":"145","author":"D Athauda","year":"2016","unstructured":"Athauda D, Foltynie T (2016a) Insulin resistance and Parkinson\u2019s disease: a new target for disease modification? Prog Neurobiol 145:98\u2013120. https:\/\/doi.org\/10.1016\/j.pneurobio.2016a.10.001","journal-title":"Prog Neurobiol"},{"key":"1702_CR7","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.1172\/JCI68295","volume":"123","author":"I Aviles-Olmos","year":"2013","unstructured":"Aviles-Olmos I, Dickson J, Kefalopoulou Z et al (2013) Exenatide and the treatment of patients with Parkinson\u2019s disease. J Clin Invest 123:2730\u20132736. https:\/\/doi.org\/10.1172\/JCI68295","journal-title":"J Clin Invest"},{"key":"1702_CR8","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1007\/s00221-016-4572-1","volume":"234","author":"AE Ayadi","year":"2016","unstructured":"Ayadi AE, Zigmond MJ, Smith AD (2016) IGF-1 protects dopamine neurons against oxidative stress: association with changes in phosphokinases. Exp Brain Res 234:1863\u20131873. https:\/\/doi.org\/10.1007\/s00221-016-4572-1","journal-title":"Exp Brain Res"},{"key":"1702_CR9","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2010.225","author":"LD Baker","year":"2011","unstructured":"Baker LD, Cross DJ, Minoshima S et al (2011) Insulin resistance and alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early Type 2 diabetes. Arch Neurol. https:\/\/doi.org\/10.1001\/archneurol.2010.225","journal-title":"Arch Neurol"},{"key":"1702_CR10","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyv024","volume":"18","author":"MG Baladi","year":"2015","unstructured":"Baladi MG, Horton RE, Owens WA et al (2015) Eating high fat chow decreases dopamine clearance in adolescent and adult male rats but selectively enhances the locomotor stimulating effects of cocaine in adolescents. Int J Neuropsychopharmacol 18:pyv024\u2013pyv024. https:\/\/doi.org\/10.1093\/ijnp\/pyv024","journal-title":"Int J Neuropsychopharmacol"},{"key":"1702_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.dscb.2024.100158","volume":"15","author":"MA Bantounou","year":"2024","unstructured":"Bantounou MA, Shoaib K, Mazzoleni A et al (2024) The association between type 2 diabetes mellitus and Parkinson\u2019s disease; a systematic review and meta-analysis. Brain Disord 15:100158. https:\/\/doi.org\/10.1016\/j.dscb.2024.100158","journal-title":"Brain Disord"},{"key":"1702_CR12","doi-asserted-by":"publisher","DOI":"10.1111\/nan.12760","author":"F Bassil","year":"2022","unstructured":"Bassil F, Delamarre A, Canron M et al (2022) Impaired brain insulin signalling in Parkinson\u2019s disease. Neuropathol Appl Neurobiol. https:\/\/doi.org\/10.1111\/nan.12760","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1702_CR14","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nrn4019","volume":"16","author":"GJ Biessels","year":"2015","unstructured":"Biessels GJ, Reagan LP (2015) Hippocampal insulin resistance and cognitive dysfunction. Nat Rev Neurosci 16:660\u2013671. https:\/\/doi.org\/10.1038\/nrn4019","journal-title":"Nat Rev Neurosci"},{"key":"1702_CR16","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s11481-013-9435-y","volume":"8","author":"F Blandini","year":"2013","unstructured":"Blandini F (2013) Neural and immune mechanisms in the pathogenesis of Parkinson\u2019s disease. J Neuroimmune Pharmacol 8:189\u2013201. https:\/\/doi.org\/10.1007\/s11481-013-9435-y","journal-title":"J Neuroimmune Pharmacol"},{"key":"1702_CR17","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1126\/science.1078223","volume":"299","author":"M Bl\u00fcher","year":"2003","unstructured":"Bl\u00fcher M, Kahn BB, Kahn CR (2003) Extended longevity in mice lacking the insulin receptor in adipose tissue. Science 299:572\u2013574. https:\/\/doi.org\/10.1126\/science.1078223","journal-title":"Science"},{"key":"1702_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2014.00161","author":"E Bl\u00c3\u00a1zquez","year":"2014","unstructured":"Bl\u00c3\u00a1zquez E, Vel\u00c3\u00a1zquez E, Hurtado-Carneiro V, Ruiz-Albusac JM (2014) Insulin in the brain: its pathophysiological implications for states related with central insulin resistance, Type 2 diabetes and Alzheimer\u00e2\u20acTMs disease. Front Endocrinol (Lausanne). https:\/\/doi.org\/10.3389\/fendo.2014.00161","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1702_CR18","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00429-010-0246-0","volume":"214","author":"P Borghammer","year":"2010","unstructured":"Borghammer P, Chakravarty M, Jonsdottir KY et al (2010) Cortical hypometabolism and hypoperfusion in Parkinson\u2019s disease is extensive: probably even at early disease stages. Brain Struct Funct 214:303\u2013317. https:\/\/doi.org\/10.1007\/s00429-010-0246-0","journal-title":"Brain Struct Funct"},{"key":"1702_CR19","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.neurobiolaging.2007.02.002","volume":"29","author":"TP Bouchard","year":"2008","unstructured":"Bouchard TP, Malykhin N, Martin WRW et al (2008) Age and dementia-associated atrophy predominates in the hippocampal head and amygdala in Parkinson\u2019s disease. Neurobiol Aging 29:1027\u20131039. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2007.02.002","journal-title":"Neurobiol Aging"},{"key":"1702_CR13","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s11481-012-9401-0","volume":"8","author":"D B\u00e9raud","year":"2013","unstructured":"B\u00e9raud D, Hathaway HA, Trecki J et al (2013) Microglial activation and antioxidant responses induced by the Parkinson\u2019s disease protein \u03b1-synuclein. J Neuroimmune Pharmacol 8:94\u2013117. https:\/\/doi.org\/10.1007\/s11481-012-9401-0","journal-title":"J Neuroimmune Pharmacol"},{"key":"1702_CR20","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1007\/s00125-024-06198-1","volume":"67","author":"M Byndloss","year":"2024","unstructured":"Byndloss M, Devkota S, Duca F et al (2024) The gut microbiota and diabetes: research, translation, and clinical applications \u2013 2023 Diabetes, Diabetes Care, and Diabetologia Expert Forum. Diabetologia 67:1760\u20131782. https:\/\/doi.org\/10.1007\/s00125-024-06198-1","journal-title":"Diabetologia"},{"key":"1702_CR21","doi-asserted-by":"publisher","first-page":"13107","DOI":"10.1074\/jbc.M110.100420","volume":"285","author":"A Caccamo","year":"2010","unstructured":"Caccamo A, Majumder S, Richardson A et al (2010) Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-\u03b2, and Tau. J Biol Chem 285:13107\u201313120. https:\/\/doi.org\/10.1074\/jbc.M110.100420","journal-title":"J Biol Chem"},{"key":"1702_CR22","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/S1474-4422(13)70118-2","volume":"12","author":"P Calabresi","year":"2013","unstructured":"Calabresi P, Castrioto A, Di Filippo M, Picconi B (2013) New experimental and clinical links between the hippocampus and the dopaminergic system in Parkinson\u2019s disease. Lancet Neurol 12:811\u2013821. https:\/\/doi.org\/10.1016\/S1474-4422(13)70118-2","journal-title":"Lancet Neurol"},{"key":"1702_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/4951379","volume":"2019","author":"F Camargo Maluf","year":"2019","unstructured":"Camargo Maluf F, Feder D, Alves de Siqueira Carvalho A (2019) Analysis of the relationship between type II diabetes mellitus and Parkinson\u2019s disease: a systematic review. Parkinsons Dis 2019:1\u201314. https:\/\/doi.org\/10.1155\/2019\/4951379","journal-title":"Parkinsons Dis"},{"key":"1702_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2014.00313","author":"M Canal","year":"2014","unstructured":"Canal M, Roman\u00c3-Aumedes J, Mart\u00c3n-Flores N et al (2014) RTP801\/REDD1: a stress coping regulator that turns into a troublemaker in neurodegenerative disorders. Front Cell Neurosci. https:\/\/doi.org\/10.3389\/fncel.2014.00313","journal-title":"Front Cell Neurosci"},{"key":"1702_CR25","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.bbrc.2016.07.004","volume":"478","author":"X Cang","year":"2016","unstructured":"Cang X, Wang X, Liu P et al (2016) PINK1 alleviates palmitate induced insulin resistance in HepG2 cells by suppressing ROS mediated MAPK pathways. Biochem Biophys Res Commun 478:431\u2013438. https:\/\/doi.org\/10.1016\/j.bbrc.2016.07.004","journal-title":"Biochem Biophys Res Commun"},{"key":"1702_CR26","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1038\/nm1202-793","volume":"8","author":"E Carro","year":"2002","unstructured":"Carro E, Trejo JL, Gomez-Isla T et al (2002) Serum insulin-like growth factor I regulates brain amyloid-\u03b2 levels. Nat Med 8:1390\u20131397. https:\/\/doi.org\/10.1038\/nm1202-793","journal-title":"Nat Med"},{"key":"1702_CR28","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1212\/WNL.0b013e3182553cc9","volume":"78","author":"E Cereda","year":"2012","unstructured":"Cereda E, Barichella M, Cassani E et al (2012a) Clinical features of Parkinson disease when onset of diabetes came first. Neurology 78:1507\u20131511. https:\/\/doi.org\/10.1212\/WNL.0b013e3182553cc9","journal-title":"Neurology"},{"key":"1702_CR27","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.2337\/dc11-1584","volume":"34","author":"E Cereda","year":"2011","unstructured":"Cereda E, Barichella M, Pedrolli C et al (2011) Diabetes and risk of Parkinson\u2019s disease. Diabetes Care 34:2614\u20132623. https:\/\/doi.org\/10.2337\/dc11-1584","journal-title":"Diabetes Care"},{"key":"1702_CR29","doi-asserted-by":"publisher","DOI":"10.1155\/2024\/8145388","author":"S Chai","year":"2024","unstructured":"Chai S, Niu Y, Liu F et al (2024) Comparison of GLP-1 receptor agonists, SGLT-2 inhibitors, and DPP-4 inhibitors as an add-on drug to insulin combined with oral hypoglycemic drugs: umbrella review. J Diabetes Res. https:\/\/doi.org\/10.1155\/2024\/8145388","journal-title":"J Diabetes Res"},{"key":"1702_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/srep09000","volume":"5","author":"KL Chang","year":"2015","unstructured":"Chang KL, Pee HN, Yang S, Ho PC (2015) Influence of drug transporters and stereoselectivity on the brain penetration of pioglitazone as a potential medicine against Alzheimer\u2019s disease. Sci Rep 5:9000. https:\/\/doi.org\/10.1038\/srep09000","journal-title":"Sci Rep"},{"key":"1702_CR31","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.tem.2010.06.005","volume":"21","author":"Z Cheng","year":"2010","unstructured":"Cheng Z, Tseng Y, White MF (2010) Insulin signaling meets mitochondria in metabolism. Trends Endocrinol Metab 21:589\u2013598. https:\/\/doi.org\/10.1016\/j.tem.2010.06.005","journal-title":"Trends Endocrinol Metab"},{"key":"1702_CR32","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3233\/JPD-191900","volume":"10","author":"JLY Cheong","year":"2020","unstructured":"Cheong JLY, de Pablo-Fernanz E, Foltynie T, Noyce AJ (2020) The association between type 2 diabetes mellitus and Parkinson\u2019s disease. J Parkinsons Dis 10:775\u2013789. https:\/\/doi.org\/10.3233\/JPD-191900","journal-title":"J Parkinsons Dis"},{"key":"1702_CR33","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.neuron.2008.04.014","volume":"58","author":"S-L Chiu","year":"2008","unstructured":"Chiu S-L, Chen C-M, Cline HT (2008) Insulin receptor signaling regulates synapse number, dendritic plasticity, and circuit function in vivo. Neuron 58:708\u2013719. https:\/\/doi.org\/10.1016\/j.neuron.2008.04.014","journal-title":"Neuron"},{"key":"1702_CR34","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.freeradbiomed.2004.12.008","volume":"38","author":"J-Y Choi","year":"2005","unstructured":"Choi J-Y, Jang E-H, Park C-S, Kang J-H (2005) Enhanced susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in high-fat diet-induced obesity. Free Radic Biol Med 38:806\u2013816. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2004.12.008","journal-title":"Free Radic Biol Med"},{"key":"1702_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2350-12-69","volume":"12","author":"J Clark","year":"2011","unstructured":"Clark J, Reddy S, Zheng K et al (2011) Association of PGC-1alphapolymorphisms with age of onset and risk of Parkinson\u2019s disease. BMC Med Genet 12:69. https:\/\/doi.org\/10.1186\/1471-2350-12-69","journal-title":"BMC Med Genet"},{"key":"1702_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0061551","volume":"8","author":"JR Colca","year":"2013","unstructured":"Colca JR, McDonald WG, Cavey GS et al (2013) Identification of a mitochondrial target of Thiazolidinedione insulin sensitizers (mTOT)\u2014relationship to newly identified mitochondrial pyruvate carrier proteins. PLoS One 8:e61551. https:\/\/doi.org\/10.1371\/journal.pone.0061551","journal-title":"PLoS One"},{"key":"1702_CR37","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1093\/aje\/kwv109","volume":"182","author":"JG Connolly","year":"2015","unstructured":"Connolly JG, Bykov K, Gagne JJ (2015) Thiazolidinediones and Parkinson disease: a cohort study. Am J Epidemiol 182:936\u2013944. https:\/\/doi.org\/10.1093\/aje\/kwv109","journal-title":"Am J Epidemiol"},{"key":"1702_CR38","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s11064-014-1377-0","volume":"40","author":"JC Corona","year":"2015","unstructured":"Corona JC, Duchen MR (2015) PPAR\u03b3 and PGC-1\u03b1 as therapeutic targets in Parkinson\u2019s. Neurochem Res 40:308\u2013316. https:\/\/doi.org\/10.1007\/s11064-014-1377-0","journal-title":"Neurochem Res"},{"key":"1702_CR39","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1093\/brain\/aws101","volume":"135","author":"C Costa","year":"2012","unstructured":"Costa C, Sgobio C, Siliquini S et al (2012) Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson\u2019s disease. Brain 135:1884\u20131899. https:\/\/doi.org\/10.1093\/brain\/aws101","journal-title":"Brain"},{"key":"1702_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104821","volume":"97","author":"L Crudele","year":"2023","unstructured":"Crudele L, Gadaleta RM, Cariello M, Moschetta A (2023) Gut microbiota in the pathogenesis and therapeutic approaches of diabetes. EBioMedicine 97:104821. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104821","journal-title":"EBioMedicine"},{"key":"1702_CR41","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.pharmthera.2018.03.004","volume":"188","author":"H Dai","year":"2018","unstructured":"Dai H, Sinclair DA, Ellis JL, Steegborn C (2018) Sirtuin activators and inhibitors: promises, achievements, and challenges. Pharmacol Ther 188:140\u2013154. https:\/\/doi.org\/10.1016\/j.pharmthera.2018.03.004","journal-title":"Pharmacol Ther"},{"key":"1702_CR42","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1097\/01.jnen.0000179050.54522.5a","volume":"64","author":"E Dalf\u00f3","year":"2005","unstructured":"Dalf\u00f3 E, Portero-Ot\u00edn M, Ayala V et al (2005) Evidence of oxidative stress in the neocortex in incidental Lewy body disease. J Neuropathol Exp Neurol 64:816\u2013830. https:\/\/doi.org\/10.1097\/01.jnen.0000179050.54522.5a","journal-title":"J Neuropathol Exp Neurol"},{"key":"1702_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s40842-025-00222-y","volume":"11","author":"T Dara","year":"2025","unstructured":"Dara T, Zabihi M, Hoseinzade F et al (2025) Bromocriptine in type 2 diabetes: a promising alternative, a systematic review and meta-analysis. Cardiovascular Diabetology \u2013 Endocrinology Reports 11:10. https:\/\/doi.org\/10.1186\/s40842-025-00222-y","journal-title":"Cardiovascular Diabetology \u2013 Endocrinology Reports"},{"key":"1702_CR47","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/s41574-020-0399-8","volume":"16","author":"CF Deacon","year":"2020","unstructured":"Deacon CF (2020) Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus. Nat Rev Endocrinol 16:642\u2013653. https:\/\/doi.org\/10.1038\/s41574-020-0399-8","journal-title":"Nat Rev Endocrinol"},{"key":"1702_CR48","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.140051","volume":"4","author":"E Deas","year":"2014","unstructured":"Deas E, Piipari K, Machhada A et al (2014) PINK1 deficiency in \u03b2-cells increases basal insulin secretion and improves glucose tolerance in mice. Open Biol 4:140051. https:\/\/doi.org\/10.1098\/rsob.140051","journal-title":"Open Biol"},{"key":"1702_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2013.12.004","author":"FG De Felice","year":"2014","unstructured":"De Felice FG, Lourenco MV, Ferreira ST (2014) How does brain insulin resistance develop in Alzheimer\u2019s disease? Alzheimer\u2019s Dementia. https:\/\/doi.org\/10.1016\/j.jalz.2013.12.004","journal-title":"Alzheimer\u2019s Dementia"},{"key":"1702_CR49","doi-asserted-by":"publisher","first-page":"793","DOI":"10.3233\/JPD-202486","volume":"11","author":"C Deischinger","year":"2021","unstructured":"Deischinger C, Dervic E, Kaleta M et al (2021) Diabetes mellitus is associated with a higher relative risk for Parkinson\u2019s disease in women than in men. J Parkinsons Dis 11:793\u2013800. https:\/\/doi.org\/10.3233\/JPD-202486","journal-title":"J Parkinsons Dis"},{"key":"1702_CR51","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.molmed.2013.04.002","volume":"19","author":"A Deleersnijder","year":"2013","unstructured":"Deleersnijder A, Gerard M, Debyser Z, Baekelandt V (2013) The remarkable conformational plasticity of alpha-synuclein: blessing or curse? Trends Mol Med 19:368\u2013377. https:\/\/doi.org\/10.1016\/j.molmed.2013.04.002","journal-title":"Trends Mol Med"},{"key":"1702_CR50","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00401-008-0355-5","volume":"115","author":"K Del Tredici","year":"2008","unstructured":"Del Tredici K, Braak H (2008) A not entirely benign procedure: progression of Parkinson\u2019s disease. Acta Neuropathol 115:379\u2013384. https:\/\/doi.org\/10.1007\/s00401-008-0355-5","journal-title":"Acta Neuropathol"},{"key":"1702_CR45","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000005771","author":"E De Pablo-Fernandez","year":"2018","unstructured":"De Pablo-Fernandez E, Goldacre R, Pakpoor J et al (2018) Association between diabetes and subsequent Parkinson disease. Neurology. https:\/\/doi.org\/10.1212\/WNL.0000000000005771","journal-title":"Neurology"},{"key":"1702_CR46","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/ane.12793","volume":"136","author":"E De Pablo-Fernandez","year":"2017","unstructured":"De Pablo-Fernandez E, Sierra-Hidalgo F, Benito-Le\u00f3n J, Bermejo-Pareja F (2017) Association between Parkinson\u2019s disease and diabetes: data from NEDICES study. Acta Neurol Scand 136:732\u2013736. https:\/\/doi.org\/10.1111\/ane.12793","journal-title":"Acta Neurol Scand"},{"key":"1702_CR52","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.1600-0404.1999.tb00721.x","volume":"100","author":"RJ Dobbs","year":"1999","unstructured":"Dobbs RJ, Charlett A, Purkiss AG et al (1999) Association of circulating TNF-\u03b1 and IL-6 with ageing and parkinsonism. Acta Neurol Scand 100:34\u201341. https:\/\/doi.org\/10.1111\/j.1600-0404.1999.tb00721.x","journal-title":"Acta Neurol Scand"},{"key":"1702_CR53","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","volume":"17","author":"ER Dorsey","year":"2018","unstructured":"Dorsey ER, Elbaz A, Nichols E et al (2018) Global, regional, and national burden of Parkinson\u2019s disease, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 17:939\u2013953. https:\/\/doi.org\/10.1016\/S1474-4422(18)30295-3","journal-title":"Lancet Neurol"},{"key":"1702_CR54","doi-asserted-by":"publisher","first-page":"428","DOI":"10.2337\/dc09-1499","volume":"33","author":"DJ Drucker","year":"2010","unstructured":"Drucker DJ, Sherman SI, Gorelick FS et al (2010) Incretin-based therapies for the treatment of type 2 diabetes: evaluation of the risks and benefits. Diabetes Care 33:428\u2013433. https:\/\/doi.org\/10.2337\/dc09-1499","journal-title":"Diabetes Care"},{"key":"1702_CR56","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.bbadis.2013.01.008","volume":"1832","author":"AI Duarte","year":"2013","unstructured":"Duarte AI, Candeias E, Correia SC et al (2013) Crosstalk between diabetes and brain: glucagon-like peptide-1 mimetics as a promising therapy against neurodegeneration. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1832:527\u2013541. https:\/\/doi.org\/10.1016\/j.bbadis.2013.01.008","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"},{"key":"1702_CR55","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.bbamcr.2008.02.016","volume":"1783","author":"AI Duarte","year":"2008","unstructured":"Duarte AI, Santos P, Oliveira CR et al (2008) Insulin neuroprotection against oxidative stress is mediated by Akt and GSK-3\u03b2 signaling pathways and changes in protein expression. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1783:994\u20131002. https:\/\/doi.org\/10.1016\/j.bbamcr.2008.02.016","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"},{"key":"1702_CR57","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1096\/fj.08-120410","volume":"23","author":"T Duka","year":"2009","unstructured":"Duka T, Duka V, Joyce JN, Sidhu A (2009) \u03b1-Synuclein contributes to GSK\u20103\u03b2\u2010catalyzed tau phosphorylation in Parkinson\u2019s disease models. FASEB J 23:2820\u20132830. https:\/\/doi.org\/10.1096\/fj.08-120410","journal-title":"FASEB J"},{"key":"1702_CR58","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.neurobiolaging.2013.11.001","volume":"35","author":"L Dunn","year":"2014","unstructured":"Dunn L, Allen GFG, Mamais A et al (2014) Dysregulation of glucose metabolism is an early event in sporadic Parkinson\u2019s disease. Neurobiol Aging 35:1111\u20131115. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2013.11.001","journal-title":"Neurobiol Aging"},{"key":"1702_CR59","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.expneurol.2007.09.022","volume":"209","author":"AD Ebert","year":"2008","unstructured":"Ebert AD, Beres AJ, Barber AE, Svendsen CN (2008) Human neural progenitor cells over-expressing IGF-1 protect dopamine neurons and restore function in a rat model of Parkinson\u2019s disease. Exp Neurol 209:213\u2013223. https:\/\/doi.org\/10.1016\/j.expneurol.2007.09.022","journal-title":"Exp Neurol"},{"key":"1702_CR60","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1073\/pnas.0605208103","volume":"104","author":"MI Ekstrand","year":"2007","unstructured":"Ekstrand MI, Terzioglu M, Galter D et al (2007) Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons. Proc Natl Acad Sci U S A 104:1325\u20131330. https:\/\/doi.org\/10.1073\/pnas.0605208103","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1702_CR61","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2174\/157340309788970333","volume":"5","author":"E Erdmann","year":"2009","unstructured":"Erdmann E, Charbonnel B, Wilcox R (2009) Thiazolidinediones and cardiovascular risk \u2014 a question of balance. Curr Cardiol Rev 5:155\u2013165. https:\/\/doi.org\/10.2174\/157340309788970333","journal-title":"Curr Cardiol Rev"},{"key":"1702_CR62","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/nn.4030","volume":"18","author":"D Erny","year":"2015","unstructured":"Erny D, de Hrab\u011b Angelis AL, Jaitin D et al (2015) Host microbiota constantly control maturation and function of microglia in the CNS. Nat Neurosci 18:965\u2013977. https:\/\/doi.org\/10.1038\/nn.4030","journal-title":"Nat Neurosci"},{"key":"1702_CR202","doi-asserted-by":"publisher","unstructured":"FehmHL, Kern W, Peters A (2006) The selfish brain: competition for energy resources. Prog Brain Res.;153:129-40. PMID: 16876572 https:\/\/doi.org\/10.1016\/S0079-6123(06)53007-9","DOI":"10.1016\/S0079-6123(06)53007-9"},{"key":"1702_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2013.12.010","author":"ST Ferreira","year":"2014","unstructured":"Ferreira ST, Clarke JR, Bomfim TR, De Felice FG (2014) Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer\u2019s disease. Alzheimer\u2019s Dement. https:\/\/doi.org\/10.1016\/j.jalz.2013.12.010. 10:","journal-title":"Alzheimer\u2019s Dement"},{"key":"1702_CR64","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1900\/RDS.2014.11.202","volume":"11","author":"TD Filippatos","year":"2014","unstructured":"Filippatos TD, Panagiotopoulou TV, Elisaf MS (2014) Adverse effects of GLP-1 receptor agonists. Rev Diabet Stud 11:202\u2013230. https:\/\/doi.org\/10.1900\/RDS.2014.11.202","journal-title":"Rev Diabet Stud"},{"key":"1702_CR65","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s40263-013-0076-8","volume":"27","author":"J Freiherr","year":"2013","unstructured":"Freiherr J, Hallschmid M, Frey WH et al (2013) Intranasal insulin as a treatment for Alzheimer\u2019s disease: a review of basic research and clinical evidence. CNS Drugs 27:505\u2013514. https:\/\/doi.org\/10.1007\/s40263-013-0076-8","journal-title":"CNS Drugs"},{"key":"1702_CR66","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s12264-017-0170-x","volume":"33","author":"ME Fullard","year":"2017","unstructured":"Fullard ME, Morley JF, Duda JE (2017) Olfactory dysfunction as an early biomarker in Parkinson\u2019s disease. Neurosci Bull 33:515\u2013525. https:\/\/doi.org\/10.1007\/s12264-017-0170-x","journal-title":"Neurosci Bull"},{"key":"1702_CR67","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.biocel.2015.03.006","volume":"64","author":"S Gao","year":"2015","unstructured":"Gao S, Duan C, Gao G et al (2015) Alpha-synuclein overexpression negatively regulates insulin receptor substrate 1 by activating mTORC1\/S6K1 signaling. Int J Biochem Cell Biol 64:25\u201333. https:\/\/doi.org\/10.1016\/j.biocel.2015.03.006","journal-title":"Int J Biochem Cell Biol"},{"key":"1702_CR68","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s12035-012-8339-9","volume":"47","author":"R Ghasemi","year":"2013","unstructured":"Ghasemi R, Haeri A, Dargahi L et al (2013) Insulin in the brain: sources, localization and functions. Mol Neurobiol 47:145\u2013171. https:\/\/doi.org\/10.1007\/s12035-012-8339-9","journal-title":"Mol Neurobiol"},{"key":"1702_CR69","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1124\/mol.106.033845","volume":"71","author":"S Ghosh","year":"2007","unstructured":"Ghosh S, Patel N, Rahn D et al (2007) The thiazolidinedione pioglitazone alters mitochondrial function in human neuron-like cells. Mol Pharmacol 71:1695\u20131702. https:\/\/doi.org\/10.1124\/mol.106.033845","journal-title":"Mol Pharmacol"},{"key":"1702_CR70","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.phrs.2015.03.010","volume":"97","author":"M Golpich","year":"2015","unstructured":"Golpich M, Amini E, Hemmati F et al (2015) Glycogen synthase kinase-3 beta (GSK-3\u03b2) signaling: implications for Parkinson\u2019s disease. Pharmacol Res 97:16\u201326. https:\/\/doi.org\/10.1016\/j.phrs.2015.03.010","journal-title":"Pharmacol Res"},{"key":"1702_CR71","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1097\/PSY.0b013e31825ff1de","volume":"74","author":"MM Gonzales","year":"2012","unstructured":"Gonzales MM, Tarumi T, Eagan DE et al (2012) Indirect effects of elevated body mass index on memory performance through altered cerebral metabolite concentrations. Psychosom Med 74:691\u2013698. https:\/\/doi.org\/10.1097\/PSY.0b013e31825ff1de","journal-title":"Psychosom Med"},{"key":"1702_CR72","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1007\/s10571-011-9671-8","volume":"31","author":"LA Greene","year":"2011","unstructured":"Greene LA, Levy O, Malagelada C (2011) Akt as a victim, villain and potential hero in Parkinson\u2019s disease pathophysiology and treatment. Cell Mol Neurobiol 31:969\u2013978. https:\/\/doi.org\/10.1007\/s10571-011-9671-8","journal-title":"Cell Mol Neurobiol"},{"key":"1702_CR73","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.1471-4159.2004.02949.x","volume":"93","author":"RJ Griffin","year":"2005","unstructured":"Griffin RJ, Moloney A, Kelliher M et al (2005) Activation of Akt\/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer\u2019s disease pathology. J Neurochem 93:105\u2013117. https:\/\/doi.org\/10.1111\/j.1471-4159.2004.02949.x","journal-title":"J Neurochem"},{"key":"1702_CR75","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1016\/j.cellsig.2014.08.019","volume":"26","author":"D Heras-Sandoval","year":"2014","unstructured":"Heras-Sandoval D, P\u00e9rez-Rojas JM, Hern\u00e1ndez-Dami\u00e1n J, Pedraza-Chaverri J (2014) The role of PI3K\/AKT\/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration. Cell Signal 26:2694\u20132701. https:\/\/doi.org\/10.1016\/j.cellsig.2014.08.019","journal-title":"Cell Signal"},{"key":"1702_CR76","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0070951","volume":"8","author":"D Hernandez-Baltazar","year":"2013","unstructured":"Hernandez-Baltazar D, Mendoza-Garrido ME, Martinez-Fong D (2013) Activation of GSK-3\u03b2 and Caspase-3 occurs in nigral dopamine neurons during the development of apoptosis activated by a striatal injection of 6-hydroxydopamine. PLoS One 8:e70951. https:\/\/doi.org\/10.1371\/journal.pone.0070951","journal-title":"PLoS One"},{"key":"1702_CR74","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.569777","author":"R He","year":"2020","unstructured":"He R, Zhao Y, He Y et al (2020) Olfactory dysfunction predicts disease progression in Parkinson\u2019s disease: a longitudinal study. Front Neurosci. https:\/\/doi.org\/10.3389\/fnins.2020.569777","journal-title":"Front Neurosci"},{"key":"1702_CR77","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/mds.25032","volume":"28","author":"EC Hirsch","year":"2013","unstructured":"Hirsch EC, Jenner P, Przedborski S (2013) Pathogenesis of Parkinson\u2019s disease. Mov Disord 28:24\u201330. https:\/\/doi.org\/10.1002\/mds.25032","journal-title":"Mov Disord"},{"key":"1702_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2024.109952","volume":"253","author":"C H\u00f6lscher","year":"2024","unstructured":"H\u00f6lscher C (2024) Glucagon-like peptide-1 class drugs show clear protective effects in Parkinson\u2019s and Alzheimer\u2019s disease clinical trials: a revolution in the making? Neuropharmacology 253:109952. https:\/\/doi.org\/10.1016\/j.neuropharm.2024.109952","journal-title":"Neuropharmacology"},{"key":"1702_CR79","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1185\/03007995.2010.549466","volume":"27","author":"JJ Holst","year":"2011","unstructured":"Holst JJ, Burcelin R, Nathanson E (2011) Neuroprotective properties of GLP-1: theoretical and practical applications. Curr Med Res Opin 27:547\u2013558. https:\/\/doi.org\/10.1185\/03007995.2010.549466","journal-title":"Curr Med Res Opin"},{"key":"1702_CR80","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/mds.22444","volume":"24","author":"Y Hosokai","year":"2009","unstructured":"Hosokai Y, Nishio Y, Hirayama K et al (2009) Distinct patterns of regional cerebral glucose metabolism in Parkinson\u2019s disease with and without mild cognitive impairment. Mov Disord 24:854\u2013862. https:\/\/doi.org\/10.1002\/mds.22444","journal-title":"Mov Disord"},{"key":"1702_CR81","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s12031-012-9734-4","volume":"47","author":"H Hsuchou","year":"2012","unstructured":"Hsuchou H, Kastin AJ, Pan W (2012) Blood-borne metabolic factors in obesity exacerbate injury-induced gliosis. J Mol Neurosci 47:267\u2013277. https:\/\/doi.org\/10.1007\/s12031-012-9734-4","journal-title":"J Mol Neurosci"},{"key":"1702_CR82","doi-asserted-by":"publisher","first-page":"842","DOI":"10.2337\/dc06-2011","volume":"30","author":"G Hu","year":"2007","unstructured":"Hu G, Jousilahti P, Bidel S et al (2007) Type 2 diabetes and the risk of Parkinson\u2019s disease. Diabetes Care 30:842\u2013847. https:\/\/doi.org\/10.2337\/dc06-2011","journal-title":"Diabetes Care"},{"key":"1702_CR83","doi-asserted-by":"publisher","first-page":"7531","DOI":"10.1073\/pnas.94.14.7531","volume":"94","author":"S Hunot","year":"1997","unstructured":"Hunot S, Brugg B, Ricard D et al (1997) Nuclear translocation of NF-\u03baB is increased in dopaminergic neurons of patients with Parkinson disease. Proc Natl Acad Sci U S A 94:7531\u20137536. https:\/\/doi.org\/10.1073\/pnas.94.14.7531","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1702_CR84","doi-asserted-by":"crossref","unstructured":"James Martins I (ed) (2015) Nutritional and Genotoxic Stress Contributes to Diabetes and Neurodegenerative Diseases such as Parkinson\u2019s and Alzheimer\u2019s Diseases. Frontiers in Clinical Drug Research - CNS and Neurological Disorders. Bentham Science, pp 158\u2013192","DOI":"10.2174\/9781608059263114030008"},{"key":"1702_CR85","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.molmed.2018.06.008","volume":"24","author":"NM Jiang","year":"2018","unstructured":"Jiang NM, Cowan M, Moonah SN, Petri WA (2018) The impact of systemic inflammation on neurodevelopment. Trends Mol Med 24:794\u2013804. https:\/\/doi.org\/10.1016\/j.molmed.2018.06.008","journal-title":"Trends Mol Med"},{"key":"1702_CR112","doi-asserted-by":"publisher","first-page":"1","DOI":"10.24966\/DMD-201X\/100019","volume":"4","author":"I J Martins","year":"2017","unstructured":"J Martins I (2017a) Nutrition therapy regulates caffeine metabolism with relevance to NAFLD and induction of type 3 diabetes. Diabetes Metab Disord 4:1\u20139. https:\/\/doi.org\/10.24966\/DMD-201X\/100019","journal-title":"Diabetes Metab Disord"},{"key":"1702_CR86","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.1002\/jnr.21787","volume":"86","author":"CG Jolivalt","year":"2008","unstructured":"Jolivalt CG, Lee CA, Beiswenger KK et al (2008) Defective insulin signaling pathway and increased glycogen synthase kinase-3 activity in the brain of diabetic mice: parallels with Alzheimer\u2019s disease and correction by insulin. J Neurosci Res 86:3265\u20133274. https:\/\/doi.org\/10.1002\/jnr.21787","journal-title":"J Neurosci Res"},{"key":"1702_CR87","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1111\/jnc.13930","volume":"140","author":"KT Jones","year":"2017","unstructured":"Jones KT, Woods C, Zhen J et al (2017) Effects of diet and insulin on dopamine transporter activity and expression in rat caudate-putamen, nucleus accumbens, and midbrain. J Neurochem 140:728\u2013740. https:\/\/doi.org\/10.1111\/jnc.13930","journal-title":"J Neurochem"},{"key":"1702_CR88","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.neuroscience.2015.03.017","volume":"294","author":"R Khang","year":"2015","unstructured":"Khang R, Park C, Shin J-H (2015) Dysregulation of parkin in the substantia nigra of db\/db and high-fat diet mice. Neuroscience 294:182\u2013192. https:\/\/doi.org\/10.1016\/j.neuroscience.2015.03.017","journal-title":"Neuroscience"},{"key":"1702_CR89","doi-asserted-by":"publisher","first-page":"29529","DOI":"10.1074\/jbc.M111.338012","volume":"287","author":"S Khasnavis","year":"2012","unstructured":"Khasnavis S, Jana A, Roy A et al (2012) Suppression of nuclear factor-\u03baB activation and inflammation in microglia by physically modified saline. J Biol Chem 287:29529\u201329542. https:\/\/doi.org\/10.1074\/jbc.M111.338012","journal-title":"J Biol Chem"},{"key":"1702_CR91","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1530\/JOE-13-0381","volume":"220","author":"M-H Kim","year":"2014","unstructured":"Kim M-H, Jee J-H, Park S et al (2014) Metformin enhances glucagon-like peptide 1 via cooperation between insulin and Wnt signaling. J Endocrinol 220:117\u2013128. https:\/\/doi.org\/10.1530\/JOE-13-0381","journal-title":"J Endocrinol"},{"key":"1702_CR90","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.nbd.2011.07.003","volume":"44","author":"SR Kim","year":"2011","unstructured":"Kim SR, Ries V, Cheng H-C et al (2011) Age and \u03b1-synuclein expression interact to reveal a dependence of dopaminergic axons on endogenous Akt\/PKB signaling. Neurobiol Dis 44:215\u2013222. https:\/\/doi.org\/10.1016\/j.nbd.2011.07.003","journal-title":"Neurobiol Dis"},{"key":"1702_CR92","doi-asserted-by":"publisher","first-page":"3463","DOI":"10.1073\/pnas.1500877112","volume":"112","author":"A Kleinridders","year":"2015","unstructured":"Kleinridders A, Cai W, Cappellucci L et al (2015) Insulin resistance in brain alters dopamine turnover and causes behavioral disorders. Proc Natl Acad Sci U S A 112:3463\u20133468. https:\/\/doi.org\/10.1073\/pnas.1500877112","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1702_CR93","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1004125","volume":"11","author":"P Klimek","year":"2015","unstructured":"Klimek P, Kautzky-Willer A, Chmiel A et al (2015) Quantification of diabetes comorbidity risks across life using nation-wide big claims data. PLoS Comput Biol 11:e1004125. https:\/\/doi.org\/10.1371\/journal.pcbi.1004125","journal-title":"PLoS Comput Biol"},{"key":"1702_CR94","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1016\/j.bbamcr.2011.04.003","volume":"1813","author":"DEA Kloet","year":"2011","unstructured":"Kloet DEA, Burgering BMT (2011) The PKB\/FOXO switch in aging and cancer. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1813:1926\u20131937. https:\/\/doi.org\/10.1016\/j.bbamcr.2011.04.003","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"},{"key":"1702_CR95","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1097\/01.wnr.0000127461.15985.07","volume":"15","author":"R Krishnamurthi","year":"2004","unstructured":"Krishnamurthi R, Stott S, Maingay M et al (2004) N-terminal tripeptide of IGF-1 improves functional deficits after 6-OHDA lesion in rats. Neuroreport 15:1601\u20131604. https:\/\/doi.org\/10.1097\/01.wnr.0000127461.15985.07","journal-title":"Neuroreport"},{"key":"1702_CR96","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-024-00449-2","volume":"13","author":"Y Kuang","year":"2024","unstructured":"Kuang Y, Mao H, Huang X et al (2024) \u03b1-Synuclein seeding amplification assays for diagnosing synucleinopathies: an innovative tool in clinical implementation. Transl Neurodegener 13:56. https:\/\/doi.org\/10.1186\/s40035-024-00449-2","journal-title":"Transl Neurodegener"},{"key":"1702_CR97","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1002\/emmm.201100177","volume":"3","author":"T Kuwabara","year":"2011","unstructured":"Kuwabara T, Kagalwala MN, Onuma Y et al (2011) Insulin biosynthesis in neuronal progenitors derived from adult hippocampus and the olfactory bulb. EMBO Mol Med 3:742\u2013754. https:\/\/doi.org\/10.1002\/emmm.201100177","journal-title":"EMBO Mol Med"},{"key":"1702_CR98","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.332122","volume":"17","author":"C Labandeira","year":"2022","unstructured":"Labandeira C, Fraga-Bau A, Arias Ron D et al (2022) Parkinson\u2019s disease and diabetes mellitus: common mechanisms and treatment repurposing. Neural Regen Res 17:1652. https:\/\/doi.org\/10.4103\/1673-5374.332122","journal-title":"Neural Regen Res"},{"key":"1702_CR99","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.phrs.2012.02.008","volume":"65","author":"C Laloux","year":"2012","unstructured":"Laloux C, Petrault M, Lecointe C et al (2012) Differential susceptibility to the PPAR-\u03b3 agonist pioglitazone in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 6-hydroxydopamine rodent models of Parkinson\u2019s disease. Pharmacol Res 65:514\u2013522. https:\/\/doi.org\/10.1016\/j.phrs.2012.02.008","journal-title":"Pharmacol Res"},{"key":"1702_CR100","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1002\/cne.23607","volume":"522","author":"O Lamm","year":"2014","unstructured":"Lamm O, Ganz J, Melamed E, Offen D (2014) Harnessing neurogenesis for the possible treatment of Parkinson\u2019s disease. J Comp Neurol 522:2817\u20132830. https:\/\/doi.org\/10.1002\/cne.23607","journal-title":"J Comp Neurol"},{"key":"1702_CR102","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1002\/mds.22662","volume":"24","author":"I Liepelt","year":"2009","unstructured":"Liepelt I, Reimold M, Maetzler W et al (2009) <article-title update=\"added\"> Cortical hypometabolism assessed by a metabolic ratio in Parkinson\u2019s disease primarily reflects cognitive deterioration\u2014[ 18 F]FDG\u2010PET. Mov Disord 24:1504\u20131511. https:\/\/doi.org\/10.1002\/mds.22662","journal-title":"Mov Disord"},{"key":"1702_CR101","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.pbb.2012.03.002","volume":"101","author":"J Li","year":"2012","unstructured":"Li J, Deng J, Sheng W, Zuo Z (2012) Metformin attenuates Alzheimer\u2019s disease-like neuropathology in obese, leptin-resistant mice. Pharmacol Biochem Behav 101:564\u2013574. https:\/\/doi.org\/10.1016\/j.pbb.2012.03.002","journal-title":"Pharmacol Biochem Behav"},{"key":"1702_CR103","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/nrendo.2009.48","volume":"5","author":"JA Lovshin","year":"2009","unstructured":"Lovshin JA, Drucker DJ (2009) Incretin-based therapies for type 2 diabetes mellitus. Nat Rev Endocrinol 5:262\u2013269. https:\/\/doi.org\/10.1038\/nrendo.2009.48","journal-title":"Nat Rev Endocrinol"},{"key":"1702_CR104","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0085781","volume":"9","author":"L Lu","year":"2014","unstructured":"Lu L, Fu D, Li H et al (2014) Diabetes and risk of Parkinson\u2019s disease: an updated meta-analysis of case-control studies. PLoS One 9:e85781. https:\/\/doi.org\/10.1371\/journal.pone.0085781","journal-title":"PLoS One"},{"key":"1702_CR106","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2024.1498756","author":"Y Luo","year":"2025","unstructured":"Luo Y, Qiao L, Li M et al (2025) Global, regional, national epidemiology and trends of Parkinson\u2019s disease from 1990 to 2021: findings from the Global Burden of Disease Study 2021. Front Aging Neurosci. https:\/\/doi.org\/10.3389\/fnagi.2024.1498756","journal-title":"Front Aging Neurosci"},{"key":"1702_CR105","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01951-9","volume":"9","author":"X Lu","year":"2024","unstructured":"Lu X, Xie Q, Pan X et al (2024) Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy. Signal Transduct Target Ther 9:262. https:\/\/doi.org\/10.1038\/s41392-024-01951-9","journal-title":"Signal Transduct Target Ther"},{"key":"1702_CR107","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1462240","author":"D Lv","year":"2024","unstructured":"Lv D, Feng P, Guan X et al (2024) Neuroprotective effects of GLP-1 class drugs in Parkinson\u2019s disease. Front Neurol. https:\/\/doi.org\/10.3389\/fneur.2024.1462240","journal-title":"Front Neurol"},{"key":"1702_CR108","first-page":"29","volume":"47","author":"Y Maeshiba","year":"1997","unstructured":"Maeshiba Y, Kiyota Y, Yamashita K et al (1997) Disposition of the new antidiabetic agent pioglitazone in rats, dogs, and monkeys. Arzneimittelforschung 47:29\u201335","journal-title":"Arzneimittelforschung"},{"key":"1702_CR109","doi-asserted-by":"publisher","first-page":"14363","DOI":"10.1523\/JNEUROSCI.3928-08.2008","volume":"28","author":"C Malagelada","year":"2008","unstructured":"Malagelada C, Jin ZH, Greene LA (2008) RTP801 is induced in Parkinson\u2019s disease and mediates neuron death by inhibiting Akt phosphorylation\/activation. J Neurosci 28:14363\u201314371. https:\/\/doi.org\/10.1523\/JNEUROSCI.3928-08.2008","journal-title":"J Neurosci"},{"key":"1702_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2011.03.001","author":"JS Marino","year":"2011","unstructured":"Marino JS, Xu Y, Hill JW (2011) Central insulin and leptin-mediated autonomic control of glucose homeostasis. Trends Endocrinol Metabolism. https:\/\/doi.org\/10.1016\/j.tem.2011.03.001","journal-title":"Trends Endocrinol Metabolism"},{"key":"1702_CR111","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4236\/aar.2016.51002","volume":"05","author":"IJ Martins","year":"2016","unstructured":"Martins IJ (2016) Anti-aging genes improve appetite regulation and reverse cell senescence and apoptosis in global populations. Adv Aging Res 05:9\u201326. https:\/\/doi.org\/10.4236\/aar.2016.51002","journal-title":"Adv Aging Res"},{"key":"1702_CR113","doi-asserted-by":"publisher","DOI":"10.21767\/2472-1158.100058","author":"IJ Martins","year":"2017","unstructured":"Martins IJ (2017b) Single gene inactivation with implications to diabetes and multiple organ dysfunction syndrome. J Clin Epigenet. https:\/\/doi.org\/10.21767\/2472-1158.100058","journal-title":"J Clin Epigenet"},{"key":"1702_CR114","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad8670","author":"O Matcovitch-Natan","year":"2016","unstructured":"Matcovitch-Natan O, Winter DR, Giladi A et al (2016) Microglia development follows a stepwise program to regulate brain homeostasis. Science. https:\/\/doi.org\/10.1126\/science.aad8670","journal-title":"Science"},{"key":"1702_CR115","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.cell.2016.05.039","volume":"166","author":"D Matheoud","year":"2016","unstructured":"Matheoud D, Sugiura A, Bellemare-Pelletier A et al (2016) Parkinson\u2019s disease-related proteins PINK1 and Parkin repress mitochondrial antigen presentation. Cell 166:314\u2013327. https:\/\/doi.org\/10.1016\/j.cell.2016.05.039","journal-title":"Cell"},{"key":"1702_CR116","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1212\/WNL.0b013e3181eee25f","volume":"75","author":"T Matsuzaki","year":"2010","unstructured":"Matsuzaki T, Sasaki K, Tanizaki Y et al (2010) Insulin resistance is associated with the pathology of Alzheimer disease. Neurology 75:764\u2013770. https:\/\/doi.org\/10.1212\/WNL.0b013e3181eee25f","journal-title":"Neurology"},{"key":"1702_CR117","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.nlm.2010.02.002","volume":"93","author":"EC McNay","year":"2010","unstructured":"McNay EC, Ong CT, McCrimmon RJ et al (2010) Hippocampal memory processes are modulated by insulin and high-fat-induced insulin resistance. Neurobiol Learn Mem 93:546\u2013553. https:\/\/doi.org\/10.1016\/j.nlm.2010.02.002","journal-title":"Neurobiol Learn Mem"},{"key":"1702_CR118","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jns.2010.03.002","volume":"293","author":"Y Miyake","year":"2010","unstructured":"Miyake Y, Tanaka K, Fukushima W et al (2010) Case\u2013control study of risk of Parkinson\u2019s disease in relation to hypertension, hypercholesterolemia, and diabetes in Japan. J Neurol Sci 293:82\u201386. https:\/\/doi.org\/10.1016\/j.jns.2010.03.002","journal-title":"J Neurol Sci"},{"key":"1702_CR119","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"VK Mootha","year":"2003","unstructured":"Mootha VK, Lindgren CM, Eriksson K-F et al (2003) PGC-1\u03b1-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34:267\u2013273. https:\/\/doi.org\/10.1038\/ng1180","journal-title":"Nat Genet"},{"key":"1702_CR120","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10048-007-0116-y","volume":"9","author":"LB Moran","year":"2008","unstructured":"Moran LB, Graeber MB (2008) Towards a pathway definition of Parkinson\u2019s disease: a complex disorder with links to cancer, diabetes and inflammation. Neurogenetics 9:1\u201313. https:\/\/doi.org\/10.1007\/s10048-007-0116-y","journal-title":"Neurogenetics"},{"key":"1702_CR122","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.expneurol.2011.06.005","volume":"231","author":"JK Morris","year":"2011","unstructured":"Morris JK, Bomhoff GL, Gorres BK et al (2011a) Insulin resistance impairs nigrostriatal dopamine function. Exp Neurol 231:171\u2013180. https:\/\/doi.org\/10.1016\/j.expneurol.2011.06.005","journal-title":"Exp Neurol"},{"key":"1702_CR121","doi-asserted-by":"publisher","first-page":"R1082","DOI":"10.1152\/ajpregu.00449.2010","volume":"299","author":"JK Morris","year":"2010","unstructured":"Morris JK, Bomhoff GL, Stanford JA, Geiger PC (2010) Neurodegeneration in an animal model of Parkinson\u2019s disease is exacerbated by a high-fat diet. Am J Physiol Regul Integr Comp Physiol 299:R1082\u2013R1090. https:\/\/doi.org\/10.1152\/ajpregu.00449.2010","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"1702_CR123","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.neulet.2011.09.027","volume":"504","author":"JK Morris","year":"2011","unstructured":"Morris JK, Seim NB, Bomhoff GL et al (2011b) Effects of unilateral nigrostriatal dopamine depletion on peripheral glucose tolerance and insulin signaling in middle aged rats. Neurosci Lett 504:219\u2013222. https:\/\/doi.org\/10.1016\/j.neulet.2011.09.027","journal-title":"Neurosci Lett"},{"key":"1702_CR124","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.neuroscience.2014.04.006","volume":"270","author":"JK Morris","year":"2014","unstructured":"Morris JK, Vidoni ED, Perea RD et al (2014) Insulin resistance and gray matter volume in neurodegenerative disease. Neuroscience 270:139\u2013147. https:\/\/doi.org\/10.1016\/j.neuroscience.2014.04.006","journal-title":"Neuroscience"},{"key":"1702_CR125","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2019474118","author":"H Nagao","year":"2021","unstructured":"Nagao H, Cai W, Wewer Albrechtsen NJ et al (2021) Distinct signaling by insulin and IGF-1 receptors and their extra- and intracellular domains. Proc Natl Acad Sci U S A. https:\/\/doi.org\/10.1073\/pnas.2019474118","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1702_CR126","doi-asserted-by":"publisher","DOI":"10.1186\/s12987-023-00431-6","volume":"20","author":"V Nguyen","year":"2023","unstructured":"Nguyen V, Thomas P, Pemberton S et al (2023) Central nervous system insulin signaling can influence the rate of insulin influx into brain. Fluids Barriers CNS 20:28. https:\/\/doi.org\/10.1186\/s12987-023-00431-6","journal-title":"Fluids Barriers CNS"},{"key":"1702_CR203","doi-asserted-by":"publisher","unstructured":"Oeckinghaus A, Hayden MS, Ghosh S (2011) Crosstalk in NF-\u03baB signaling pathways. Nat Immunol. ;12(8):695-708. 10.1038\/ni.2065. PMID: 21772278 https:\/\/doi.org\/10.1038\/ni.2065","DOI":"10.1038\/ni.2065"},{"key":"1702_CR128","doi-asserted-by":"publisher","first-page":"8754","DOI":"10.1073\/pnas.0803955106","volume":"106","author":"GC O\u2019Keeffe","year":"2009","unstructured":"O\u2019Keeffe GC, Tyers P, Aarsland D et al (2009) Dopamine-induced proliferation of adult neural precursor cells in the mammalian subventricular zone is mediated through EGF. Proc Natl Acad Sci 106:8754\u20138759. https:\/\/doi.org\/10.1073\/pnas.0803955106","journal-title":"Proc Natl Acad Sci"},{"key":"1702_CR127","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.exger.2013.02.025","volume":"48","author":"C O\u2019 Neill","year":"2013","unstructured":"O\u2019 Neill C (2013) PI3-kinase\/Akt\/mTOR signaling: impaired on\/off switches in aging, cognitive decline and Alzheimer\u2019s disease. Exp Gerontol 48:647\u2013653. https:\/\/doi.org\/10.1016\/j.exger.2013.02.025","journal-title":"Exp Gerontol"},{"key":"1702_CR129","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1002\/acn3.51343","volume":"8","author":"R Ou","year":"2021","unstructured":"Ou R, Wei Q, Hou Y et al (2021) Effect of diabetes control status on the progression of Parkinson\u2019s disease: A prospective study. Ann Clin Transl Neurol 8:887\u2013897. https:\/\/doi.org\/10.1002\/acn3.51343","journal-title":"Ann Clin Transl Neurol"},{"key":"1702_CR130","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000005475","author":"G Pagano","year":"2018","unstructured":"Pagano G, Polychronis S, Wilson H et al (2018) Diabetes mellitus and Parkinson disease. Neurology. https:\/\/doi.org\/10.1212\/WNL.0000000000005475","journal-title":"Neurology"},{"key":"1702_CR131","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s10072-012-1250-3","volume":"34","author":"PL Pan","year":"2013","unstructured":"Pan PL, Shi HC, Zhong JG et al (2013) Gray matter atrophy in Parkinson\u2019s disease with dementia: evidence from meta-analysis of voxel-based morphometry studies. Neurol Sci 34:613\u2013619. https:\/\/doi.org\/10.1007\/s10072-012-1250-3","journal-title":"Neurol Sci"},{"key":"1702_CR132","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s40035-025-00526-0","volume":"14","author":"T Pavel","year":"2025","unstructured":"Pavel T, Georgy Z, Eugenia N et al (2025) Microfluidic platform for understanding Parkinson\u2019s disease and \u03b1-synuclein conformation. Transl Neurodegener 14:71. https:\/\/doi.org\/10.1186\/s40035-025-00526-0","journal-title":"Transl Neurodegener"},{"key":"1702_CR133","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1111\/j.1474-9726.2009.00493.x","volume":"8","author":"L Pawlikowska","year":"2009","unstructured":"Pawlikowska L, Hu D, Huntsman S et al (2009) Association of common genetic variation in the insulin\/IGF1 signaling pathway with human longevity. Aging Cell 8:460\u2013472. https:\/\/doi.org\/10.1111\/j.1474-9726.2009.00493.x","journal-title":"Aging Cell"},{"key":"1702_CR134","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nature18646","volume":"535","author":"HK Pedersen","year":"2016","unstructured":"Pedersen HK, Gudmundsdottir V, Nielsen HB et al (2016) Human gut microbes impact host serum metabolome and insulin sensitivity. Nature 535:376\u2013381. https:\/\/doi.org\/10.1038\/nature18646","journal-title":"Nature"},{"key":"1702_CR136","doi-asserted-by":"publisher","first-page":"29967","DOI":"10.1038\/srep29967","volume":"6","author":"G Perruolo","year":"2016","unstructured":"Perruolo G, Viggiano D, Fiory F et al (2016) Parkinson-like phenotype in insulin-resistant PED\/PEA-15 transgenic mice. Sci Rep 6:29967. https:\/\/doi.org\/10.1038\/srep29967","journal-title":"Sci Rep"},{"key":"1702_CR137","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/nri2015","volume":"7","author":"VH Perry","year":"2007","unstructured":"Perry VH, Cunningham C, Holmes C (2007) Systemic infections and inflammation affect chronic neurodegeneration. Nat Rev Immunol 7:161\u2013167. https:\/\/doi.org\/10.1038\/nri2015","journal-title":"Nat Rev Immunol"},{"key":"1702_CR138","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.acra.2015.07.014","volume":"23","author":"M Petrou","year":"2016","unstructured":"Petrou M, Davatzikos C, Hsieh M et al (2016) Diabetes, gray matter loss, and cognition in the setting of Parkinson disease. Acad Radiol 23:577\u2013581. https:\/\/doi.org\/10.1016\/j.acra.2015.07.014","journal-title":"Acad Radiol"},{"key":"1702_CR139","doi-asserted-by":"crossref","unstructured":"Picconi B, Piccoli G, Calabresi P (2012) Synaptic Dysfunction in Parkinson\u2019s Disease. pp 553\u2013572","DOI":"10.1007\/978-3-7091-0932-8_24"},{"key":"1702_CR140","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.parkreldis.2005.09.004","volume":"12","author":"KM Powers","year":"2006","unstructured":"Powers KM, Smith-Weller T, Franklin GM et al (2006) Diabetes, smoking, and other medical conditions in relation to Parkinson\u2019s disease risk. Parkinsonism Relat Disord 12:185\u2013189. https:\/\/doi.org\/10.1016\/j.parkreldis.2005.09.004","journal-title":"Parkinsonism Relat Disord"},{"key":"1702_CR141","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/S2213-8587(13)70214-6","volume":"2","author":"RE Pratley","year":"2014","unstructured":"Pratley RE, Nauck MA, Barnett AH et al (2014) Once-weekly albiglutide versus once-daily liraglutide in patients with type 2 diabetes inadequately controlled on oral drugs (HARMONY 7): a randomised, open-label, multicentre, non-inferiority phase 3 study. Lancet Diabetes Endocrinol 2:289\u2013297. https:\/\/doi.org\/10.1016\/S2213-8587(13)70214-6","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1702_CR135","doi-asserted-by":"publisher","first-page":"e1209","DOI":"10.1038\/cddis.2014.175","volume":"5","author":"BI P\u00e9rez-Revuelta","year":"2014","unstructured":"P\u00e9rez-Revuelta BI, Hettich MM, Ciociaro A et al (2014) Metformin lowers Ser-129 phosphorylated \u03b1-synuclein levels via mTOR-dependent protein phosphatase 2A activation. Cell Death Dis 5:e1209\u2013e1209. https:\/\/doi.org\/10.1038\/cddis.2014.175","journal-title":"Cell Death Dis"},{"key":"1702_CR142","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1001\/jamaneurol.2016.2742","volume":"73","author":"X-Y Qin","year":"2016","unstructured":"Qin X-Y, Zhang S-P, Cao C et al (2016) Aberrations in Peripheral Inflammatory Cytokine Levels in Parkinson Disease. JAMA Neurol 73:1316. https:\/\/doi.org\/10.1001\/jamaneurol.2016.2742","journal-title":"JAMA Neurol"},{"key":"1702_CR143","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0089229","volume":"9","author":"JJ Ramos-Rodriguez","year":"2014","unstructured":"Ramos-Rodriguez JJ, Molina-Gil S, Ortiz-Barajas O et al (2014) Central proliferation and neurogenesis is impaired in type 2 diabetes and prediabetes animal models. PLoS One 9:e89229. https:\/\/doi.org\/10.1371\/journal.pone.0089229","journal-title":"PLoS One"},{"key":"1702_CR144","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.expneurol.2011.02.004","volume":"233","author":"LP Reagan","year":"2012","unstructured":"Reagan LP (2012) Diabetes as a chronic metabolic stressor: causes, consequences and clinical complications. Exp Neurol 233:68\u201378. https:\/\/doi.org\/10.1016\/j.expneurol.2011.02.004","journal-title":"Exp Neurol"},{"key":"1702_CR145","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.bbi.2008.07.003","volume":"23","author":"M Reale","year":"2009","unstructured":"Reale M, Iarlori C, Thomas A et al (2009) Peripheral cytokines profile in Parkinson\u2019s disease. Brain Behav Immun 23:55\u201363. https:\/\/doi.org\/10.1016\/j.bbi.2008.07.003","journal-title":"Brain Behav Immun"},{"key":"1702_CR146","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/454696","volume":"2014","author":"M Regensburger","year":"2014","unstructured":"Regensburger M, Prots I, Winner B (2014) Adult hippocampal neurogenesis in Parkinson\u2019s disease: impact on neuronal survival and plasticity. Neural Plast 2014:1\u201312. https:\/\/doi.org\/10.1155\/2014\/454696","journal-title":"Neural Plast"},{"key":"1702_CR147","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1212\/01.WNL.0000265401.62434.36","volume":"70","author":"MA Reger","year":"2008","unstructured":"Reger MA, Watson GS, Green PS et al (2008a) Intranasal insulin improves cognition and modulates \u03b2-amyloid in early AD. Neurology 70:440\u2013448. https:\/\/doi.org\/10.1212\/01.WNL.0000265401.62434.36","journal-title":"Neurology"},{"key":"1702_CR148","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3233\/JAD-2008-13309","volume":"13","author":"MA Reger","year":"2008","unstructured":"Reger MA, Watson GS, Green PS et al (2008b) Intranasal Insulin Administration Dose-Dependently Modulates Verbal Memory and Plasma Amyloid-\u03b2 in Memory-Impaired Older Adults. J Alzheimer\u2019s Disease 13:323\u2013331. https:\/\/doi.org\/10.3233\/JAD-2008-13309","journal-title":"J Alzheimer\u2019s Disease"},{"key":"1702_CR149","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.00521","author":"EM Rhea","year":"2019","unstructured":"Rhea EM, Banks WA (2019) Role of the blood-brain barrier in central nervous system insulin resistance. Front Neurosci. https:\/\/doi.org\/10.3389\/fnins.2019.00521","journal-title":"Front Neurosci"},{"key":"1702_CR150","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.2337\/dc19-0760","volume":"43","author":"SY Rhee","year":"2020","unstructured":"Rhee SY, Han K-D, Kwon H et al (2020) Association between glycemic status and the risk of Parkinson disease: a nationwide population-based study. Diabetes Care 43:2169\u20132175. https:\/\/doi.org\/10.2337\/dc19-0760","journal-title":"Diabetes Care"},{"key":"1702_CR151","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1172\/JCI67227","volume":"123","author":"NB Ruderman","year":"2013","unstructured":"Ruderman NB, Carling D, Prentki M, Cacicedo JM (2013) AMPK, insulin resistance, and the metabolic syndrome. J Clin Invest 123:2764\u20132772. https:\/\/doi.org\/10.1172\/JCI67227","journal-title":"J Clin Invest"},{"key":"1702_CR152","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2020.108173","volume":"175","author":"Y-K Ryu","year":"2020","unstructured":"Ryu Y-K, Go J, Park H-Y et al (2020) Metformin regulates astrocyte reactivity in Parkinson\u2019s disease and normal aging. Neuropharmacology 175:108173. https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108173","journal-title":"Neuropharmacology"},{"key":"1702_CR153","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","volume":"167","author":"TR Sampson","year":"2016","unstructured":"Sampson TR, Debelius JW, Thron T et al (2016) Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson\u2019s Disease. Cell 167:1469\u20131480e12. https:\/\/doi.org\/10.1016\/j.cell.2016.11.018","journal-title":"Cell"},{"key":"1702_CR154","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3109\/00207459309003322","volume":"69","author":"R Sandyk","year":"1993","unstructured":"Sandyk R (1993) The relationship between diabetes mellitus and Parkinson\u2019S disease. Int J Neurosci 69:125\u2013130. https:\/\/doi.org\/10.3109\/00207459309003322","journal-title":"Int J Neurosci"},{"key":"1702_CR155","doi-asserted-by":"publisher","first-page":"5351","DOI":"10.3390\/ijms22105351","volume":"22","author":"P Sanz","year":"2021","unstructured":"Sanz P, Serratosa JM, S\u00e1nchez MP (2021) Beneficial effects of metformin on the central nervous system, with a focus on epilepsy and Lafora disease. Int J Mol Sci 22:5351. https:\/\/doi.org\/10.3390\/ijms22105351","journal-title":"Int J Mol Sci"},{"key":"1702_CR156","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S1474-4422(07)70327-7","volume":"7","author":"AH Schapira","year":"2008","unstructured":"Schapira AH (2008a) Mitochondria in the aetiology and pathogenesis of Parkinson\u2019s disease. Lancet Neurol 7:97\u2013109. https:\/\/doi.org\/10.1016\/S1474-4422(07)70327-7","journal-title":"Lancet Neurol"},{"key":"1702_CR157","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.2337\/dc10-1333","volume":"34","author":"E Schernhammer","year":"2011","unstructured":"Schernhammer E, Hansen J, Rugbjerg K et al (2011) Diabetes and the risk of developing Parkinson\u2019s disease in Denmark. Diabetes Care 34:1102\u20131108. https:\/\/doi.org\/10.2337\/dc10-1333","journal-title":"Diabetes Care"},{"key":"1702_CR158","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1111\/ejn.12434","volume":"39","author":"H Schroll","year":"2014","unstructured":"Schroll H, Vitay J, Hamker FH (2014) Dysfunctional and compensatory synaptic plasticity in <\u2009scp>P<\/scp> arkinson\u2019s disease. Eur J Neurosci 39:688\u2013702. https:\/\/doi.org\/10.1111\/ejn.12434","journal-title":"Eur J Neurosci"},{"key":"1702_CR159","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.1073\/pnas.0308724101","volume":"101","author":"M Schubert","year":"2004","unstructured":"Schubert M, Gautam D, Surjo D et al (2004) Role for neuronal insulin resistance in neurodegenerative diseases. Proceedings of the National Academy of Sciences 101:3100\u20133105. https:\/\/doi.org\/10.1073\/pnas.0308724101","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"1702_CR160","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1096\/fj.07-9261com","volume":"22","author":"C Selman","year":"2008","unstructured":"Selman C, Lingard S, Choudhury AI et al (2008) Evidence for lifespan extension and delayed age\u2013related biomarkers in insulin receptor substrate 1 null mice. FASEB J 22:807\u2013818. https:\/\/doi.org\/10.1096\/fj.07-9261com","journal-title":"FASEB J"},{"key":"1702_CR161","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1177\/0269881111434620","volume":"26","author":"AN Sharma","year":"2012","unstructured":"Sharma AN, Elased KM, Lucot JB (2012) Rosiglitazone treatment reversed depression- but not psychosis-like behavior of db\/db diabetic mice. J Psychopharmacol 26:724\u2013732. https:\/\/doi.org\/10.1177\/0269881111434620","journal-title":"J Psychopharmacol"},{"key":"1702_CR162","doi-asserted-by":"publisher","DOI":"10.1038\/srep12531","volume":"5","author":"SK Sharma","year":"2015","unstructured":"Sharma SK, Chorell E, Steneberg P et al (2015) Insulin-degrading enzyme prevents \u03b1-synuclein fibril formation in a nonproteolytical manner. Sci Rep 5:12531. https:\/\/doi.org\/10.1038\/srep12531","journal-title":"Sci Rep"},{"key":"1702_CR163","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2013.12.008","author":"SM Steculorum","year":"2014","unstructured":"Steculorum SM, Solas M, Br\u00fcning JC (2014) The paradox of neuronal insulin action and resistance in the development of aging-associated diseases. Alzheimers Dement. https:\/\/doi.org\/10.1016\/j.jalz.2013.12.008","journal-title":"Alzheimers Dement"},{"key":"1702_CR164","doi-asserted-by":"publisher","first-page":"3791","DOI":"10.1073\/pnas.1014715108","volume":"108","author":"L Stoica","year":"2011","unstructured":"Stoica L, Zhu PJ, Huang W et al (2011) Selective pharmacogenetic inhibition of mammalian target of Rapamycin complex I (mTORC1) blocks long-term synaptic plasticity and memory storage. Proceedings of the National Academy of Sciences 108:3791\u20133796. https:\/\/doi.org\/10.1073\/pnas.1014715108","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"1702_CR165","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9543","volume":"6","author":"MA Stouffer","year":"2015","unstructured":"Stouffer MA, Woods CA, Patel JC et al (2015) Insulin enhances striatal dopamine release by activating cholinergic interneurons and thereby signals reward. Nat Commun 6:8543. https:\/\/doi.org\/10.1038\/ncomms9543","journal-title":"Nat Commun"},{"key":"1702_CR166","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1021\/mp300518e","volume":"10","author":"N Strazielle","year":"2013","unstructured":"Strazielle N, Ghersi-Egea JF (2013) Physiology of blood\u2013brain interfaces in relation to brain disposition of small compounds and macromolecules. Mol Pharm 10:1473\u20131491. https:\/\/doi.org\/10.1021\/mp300518e","journal-title":"Mol Pharm"},{"key":"1702_CR167","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.tox.2010.01.001","volume":"271","author":"X Sun","year":"2010","unstructured":"Sun X, Huang L, Zhang M et al (2010) Insulin like growth factor-1 prevents 1-mentyl-4-phenylphyridinium-induced apoptosis in PC12 cells through activation of glycogen synthase kinase-3beta. Toxicology 271:5\u201312. https:\/\/doi.org\/10.1016\/j.tox.2010.01.001","journal-title":"Toxicology"},{"key":"1702_CR168","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1002\/mds.26734","volume":"31","author":"P Svenningsson","year":"2016","unstructured":"Svenningsson P, Wirdefeldt K, Yin L et al (2016) Reduced incidence of Parkinson\u2019s disease after dipeptidyl peptidase-4 inhibitors\u2014a nationwide case\u2010control study. Mov Disord 31:1422\u20131423. https:\/\/doi.org\/10.1002\/mds.26734","journal-title":"Mov Disord"},{"key":"1702_CR169","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/ana.24448","volume":"78","author":"E Svensson","year":"2015","unstructured":"Svensson E, Horv\u00e1th-Puh\u00f3 E, Thomsen RW et al (2015) Vagotomy and subsequent risk of <\u2009scp>P arkinson\u2019s disease. Ann Neurol 78:522\u2013529. https:\/\/doi.org\/10.1002\/ana.24448","journal-title":"Ann Neurol"},{"key":"1702_CR170","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1179\/1743132813Y.0000000305","volume":"36","author":"C Swanson","year":"2014","unstructured":"Swanson C, Emborg M (2014) Expression of peroxisome proliferator-activated receptor-gamma in the substantia nigra of hemiparkinsonian nonhuman primates. Neurol Res 36:634\u2013646. https:\/\/doi.org\/10.1179\/1743132813Y.0000000305","journal-title":"Neurol Res"},{"key":"1702_CR171","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1126\/science.1142179","volume":"317","author":"A Taguchi","year":"2007","unstructured":"Taguchi A, Wartschow LM, White MF (2007) Brain IRS2 signaling coordinates life span and nutrient homeostasis. Sci (1979) 317:369\u2013372. https:\/\/doi.org\/10.1126\/science.1142179","journal-title":"Sci (1979)"},{"key":"1702_CR172","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1038\/nn.2372","volume":"12","author":"LS Tain","year":"2009","unstructured":"Tain LS, Mortiboys H, Tao RN et al (2009) Rapamycin activation of 4E-BP prevents parkinsonian dopaminergic neuron loss. Nat Neurosci 12:1129\u20131135. https:\/\/doi.org\/10.1038\/nn.2372","journal-title":"Nat Neurosci"},{"key":"1702_CR173","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2013.12.007","author":"K Talbot","year":"2014","unstructured":"Talbot K, Wang H-Y (2014a) The nature, significance, and glucagon-like peptide\u20101 analog treatment of brain insulin resistance in Alzheimer\u2019s disease. Alzheimer\u2019s Dement. https:\/\/doi.org\/10.1016\/j.jalz.2013.12.007. 10:","journal-title":"Alzheimer\u2019s Dement"},{"key":"1702_CR174","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2013.12.007","author":"K Talbot","year":"2014","unstructured":"Talbot K, Wang H-Y (2014b) The nature, significance, and glucagon-like peptide\u20101 analog treatment of brain insulin resistance in Alzheimer\u2019s disease. Alzheimer\u2019s Dement. https:\/\/doi.org\/10.1016\/j.jalz.2013.12.007. 10:","journal-title":"Alzheimer\u2019s Dement"},{"key":"1702_CR175","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1002\/mdc3.13893","volume":"10","author":"H Tang","year":"2023","unstructured":"Tang H, Lu Y, Okun MS et al (2023) Meta-analysis of association between newer glucose\u2010lowering drugs and risk of Parkinson\u2019s disease. Mov Disord Clin Pract 10:1659\u20131665. https:\/\/doi.org\/10.1002\/mdc3.13893","journal-title":"Mov Disord Clin Pract"},{"key":"1702_CR176","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.neulet.2009.09.055","volume":"467","author":"S Timmons","year":"2009","unstructured":"Timmons S, Coakley MF, Moloney AM, O\u2019 Neill C (2009) Akt signal transduction dysfunction in Parkinson\u2019s disease. Neurosci Lett 467:30\u201335. https:\/\/doi.org\/10.1016\/j.neulet.2009.09.055","journal-title":"Neurosci Lett"},{"key":"1702_CR177","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.pneurobio.2006.06.003","volume":"79","author":"LP van der Heide","year":"2006","unstructured":"van der Heide LP, Ramakers GMJ, Smidt MP (2006) Insulin signaling in the central nervous system: learning to survive. Prog Neurobiol 79:205\u2013221. https:\/\/doi.org\/10.1016\/j.pneurobio.2006.06.003","journal-title":"Prog Neurobiol"},{"key":"1702_CR178","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1474-9728.2005.00148.x","volume":"4","author":"D Van Heemst","year":"2005","unstructured":"Van Heemst D, Beekman M, Mooijaart SP et al (2005) Reduced insulin\/IGF-1 signalling and human longevity. Aging Cell 4:79\u201385. https:\/\/doi.org\/10.1111\/j.1474-9728.2005.00148.x","journal-title":"Aging Cell"},{"key":"1702_CR179","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1212\/01.wnl.0000266593.50534.e8","volume":"69","author":"D Verbaan","year":"2007","unstructured":"Verbaan D, Marinus J, Visser M et al (2007) Patient-reported autonomic symptoms in Parkinson disease. Neurology 69:333\u2013341. https:\/\/doi.org\/10.1212\/01.wnl.0000266593.50534.e8","journal-title":"Neurology"},{"key":"1702_CR180","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.parkreldis.2012.03.010","volume":"18","author":"ML Wahlqvist","year":"2012","unstructured":"Wahlqvist ML, Lee M-S, Hsu C-C et al (2012) Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson\u2019s disease occurring with Type 2 diabetes in a Taiwanese population cohort. Parkinsonism Relat Disord 18:753\u2013758. https:\/\/doi.org\/10.1016\/j.parkreldis.2012.03.010","journal-title":"Parkinsonism Relat Disord"},{"key":"1702_CR182","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.expneurol.2013.11.001","volume":"251","author":"L Wang","year":"2014","unstructured":"Wang L, Zhai Y-Q, Xu L-L et al (2014a) Metabolic inflammation exacerbates dopaminergic neuronal degeneration in response to acute MPTP challenge in type 2 diabetes mice. Exp Neurol 251:22\u201329. https:\/\/doi.org\/10.1016\/j.expneurol.2013.11.001","journal-title":"Exp Neurol"},{"key":"1702_CR183","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.jocn.2013.08.017","volume":"21","author":"S Wang","year":"2014","unstructured":"Wang S, Zhang C, Sheng X et al (2014b) Peripheral expression of MAPK pathways in Alzheimer\u2019s and Parkinson\u2019s diseases. J Clin Neurosci 21:810\u2013814. https:\/\/doi.org\/10.1016\/j.jocn.2013.08.017","journal-title":"J Clin Neurosci"},{"key":"1702_CR181","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.freeradbiomed.2011.01.032","volume":"50","author":"X-J Wang","year":"2011","unstructured":"Wang X-J, Zhang S, Yan Z-Q et al (2011) Impaired CD200\u2013CD200R-mediated microglia silencing enhances midbrain dopaminergic neurodegeneration: roles of aging, superoxide, NADPH oxidase, and p38 MAPK. Free Radic Biol Med 50:1094\u20131106. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2011.01.032","journal-title":"Free Radic Biol Med"},{"key":"1702_CR184","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1097\/00019442-200511000-00005","volume":"13","author":"GS Watson","year":"2005","unstructured":"Watson GS, Cholerton BA, Reger MA et al (2005) Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with Rosiglitazone. Am J Geriatr Psychiatry 13:950\u2013958. https:\/\/doi.org\/10.1097\/00019442-200511000-00005","journal-title":"Am J Geriatr Psychiatry"},{"key":"1702_CR185","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2019.104551","volume":"113","author":"H Wei","year":"2020","unstructured":"Wei H, Zapata RC, Lopez-Valencia M et al (2020) Dopamine D2 receptor signaling modulates pancreatic beta cell circadian rhythms. Psychoneuroendocrinology 113:104551. https:\/\/doi.org\/10.1016\/j.psyneuen.2019.104551","journal-title":"Psychoneuroendocrinology"},{"key":"1702_CR186","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1001\/jamaneurol.2015.0613","volume":"72","author":"AA Willette","year":"2015","unstructured":"Willette AA, Bendlin BB, Starks EJ et al (2015a) Association of Insulin Resistance With Cerebral Glucose Uptake in Late Middle\u2013Aged Adults at Risk for Alzheimer Disease. JAMA Neurol 72:1013. https:\/\/doi.org\/10.1001\/jamaneurol.2015.0613","journal-title":"JAMA Neurol"},{"key":"1702_CR187","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.jalz.2014.03.011","volume":"11","author":"AA Willette","year":"2015","unstructured":"Willette AA, Johnson SC, Birdsill AC et al (2015b) Insulin resistance predicts brain amyloid deposition in late middle-aged adults. Alzheimer\u2019s Dement 11:504. https:\/\/doi.org\/10.1016\/j.jalz.2014.03.011","journal-title":"Alzheimer\u2019s Dement"},{"key":"1702_CR188","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1002\/mds.26563","volume":"31","author":"CH Williams-Gray","year":"2016","unstructured":"Williams-Gray CH, Wijeyekoon R, Yarnall AJ et al (2016) ) <\u2009scp>S erum immune markers and disease progression in an incident\u2009<\u2009scp>P arkinson\u2019s disease cohort (<\u2009scp>ICICLE\u2010PD). Mov Disord 31:995\u20131003. https:\/\/doi.org\/10.1002\/mds.26563","journal-title":"Mov Disord"},{"key":"1702_CR189","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.expneurol.2010.06.017","volume":"225","author":"J Wills","year":"2010","unstructured":"Wills J, Jones J, Haggerty T et al (2010) Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson\u2019s disease brains with and without dementia. Exp Neurol 225:210\u2013218. https:\/\/doi.org\/10.1016\/j.expneurol.2010.06.017","journal-title":"Exp Neurol"},{"issue":"7","key":"1702_CR190","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1001\/jamaneurol.2017.0469","volume":"74","author":"A Witoelar","year":"2017","unstructured":"Witoelar A, Jansen IE, Wang Y et al (2017) Genome-wide pleiotropy between Parkinson disease and autoimmune diseases. JAMA Neurol 74:780. https:\/\/doi.org\/10.1001\/jamaneurol.2017.0469","journal-title":"JAMA Neurol"},{"key":"1702_CR191","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.neulet.2008.03.026","volume":"436","author":"G Xiromerisiou","year":"2008","unstructured":"Xiromerisiou G, Hadjigeorgiou GM, Papadimitriou A et al (2008) Association between AKT1 gene and Parkinson\u2019s disease: a protective haplotype. Neurosci Lett 436:232\u2013234. https:\/\/doi.org\/10.1016\/j.neulet.2008.03.026","journal-title":"Neurosci Lett"},{"key":"1702_CR192","doi-asserted-by":"publisher","first-page":"910","DOI":"10.2337\/dc10-1922","volume":"34","author":"Q Xu","year":"2011","unstructured":"Xu Q, Park Y, Huang X et al (2011) Diabetes and risk of Parkinson\u2019s disease. Diabetes Care 34:910\u2013915. https:\/\/doi.org\/10.2337\/dc10-1922","journal-title":"Diabetes Care"},{"key":"1702_CR193","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1016\/j.cellsig.2014.04.009","volume":"26","author":"Y Xu","year":"2014","unstructured":"Xu Y, Liu C, Chen S et al (2014) Activation of AMPK and inactivation of Akt result in suppression of mTOR-mediated S6K1 and 4E-BP1 pathways leading to neuronal cell death in in vitro models of Parkinson\u2019s disease. Cell Signal 26:1680\u20131689. https:\/\/doi.org\/10.1016\/j.cellsig.2014.04.009","journal-title":"Cell Signal"},{"key":"1702_CR194","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1210\/en.2011-0004","volume":"152","author":"N Yamada","year":"2011","unstructured":"Yamada N, Katsuura G, Ochi Y et al (2011) Impaired CNS leptin action is implicated in depression associated with obesity. Endocrinology 152:2634\u20132643. https:\/\/doi.org\/10.1210\/en.2011-0004","journal-title":"Endocrinology"},{"key":"1702_CR195","doi-asserted-by":"publisher","first-page":"e5921","DOI":"10.1097\/MD.0000000000005921","volume":"96","author":"Y-W Yang","year":"2017","unstructured":"Yang Y-W, Hsieh T-F, Li C-I et al (2017) Increased risk of Parkinson disease with diabetes mellitus in a population-based study. Medicine 96:e5921. https:\/\/doi.org\/10.1097\/MD.0000000000005921","journal-title":"Medicine"},{"key":"1702_CR196","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.toxlet.2014.11.029","volume":"233","author":"Y Yuan","year":"2015","unstructured":"Yuan Y, Yan W, Sun J et al (2015) The molecular mechanism of rotenone-induced \u03b1-synuclein aggregation: emphasizing the role of the calcium\/GSK3\u03b2 pathway. Toxicol Lett 233:163\u2013171. https:\/\/doi.org\/10.1016\/j.toxlet.2014.11.029","journal-title":"Toxicol Lett"},{"key":"1702_CR197","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003549","volume":"95","author":"X Yue","year":"2016","unstructured":"Yue X, Li H, Yan H et al (2016) Risk of Parkinson disease in diabetes mellitus. Med 95:e3549. https:\/\/doi.org\/10.1097\/MD.0000000000003549","journal-title":"Med"},{"key":"1702_CR198","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1124\/jpet.110.165829","volume":"333","author":"F Zhang","year":"2010","unstructured":"Zhang F, Qian L, Flood PM et al (2010) Inhibition of I\u03baB kinase-\u03b2 protects dopamine neurons against lipopolysaccharide-induced neurotoxicity. J Pharmacol Exp Ther 333:822\u2013833. https:\/\/doi.org\/10.1124\/jpet.110.165829","journal-title":"J Pharmacol Exp Ther"},{"key":"1702_CR199","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.2337\/db14-1000","volume":"64","author":"H Zhang","year":"2015","unstructured":"Zhang H, Hao Y, Manor B et al (2015) Intranasal insulin enhanced resting-state functional connectivity of hippocampal regions in type 2 diabetes. Diabetes 64:1025\u20131034. https:\/\/doi.org\/10.2337\/db14-1000","journal-title":"Diabetes"},{"key":"1702_CR200","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.bbadis.2008.10.014","volume":"1792","author":"W-Q Zhao","year":"2009","unstructured":"Zhao W-Q, Townsend M (2009) Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer\u2019s disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1792:482\u2013496. https:\/\/doi.org\/10.1016\/j.bbadis.2008.10.014","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"},{"key":"1702_CR201","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3001059","author":"B Zheng","year":"2010","unstructured":"Zheng B, Liao Z, Locascio JJ et al (2010) PGC-1 \u03b1, A Potential Therapeutic Target for Early Intervention in Parkinson\u2019s Disease. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.3001059. 2:","journal-title":"Sci Transl Med"}],"container-title":["Cellular and Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10571-026-01702-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-026-01702-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-026-01702-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T02:20:17Z","timestamp":1778725217000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10571-026-01702-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,3]]},"references-count":203,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1702"],"URL":"https:\/\/doi.org\/10.1007\/s10571-026-01702-0","relation":{},"ISSN":["1573-6830"],"issn-type":[{"value":"1573-6830","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,3]]},"assertion":[{"value":"29 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"86"}}